Health
3 min read
Zantac Shaping up to be Different Than Valsartan and Metformin When It Comes to Source of NDMA
On April 1, 2020, the U.S. Food and Drug Administration (FDA) requested the recall of all Zantac (ranitidine) products from the market because of potential N-nitrosodimethylamine (NDMA) levels found. NDMA is a potent cancer-causing agent. The question is, where did this NDMA come from? While…